Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

259 Press Releases
DateTitleCompany
29 Apr 16 Phase 3 Trial Results for the Oral Proteasome Inhibitor Ixazomib Published in The New England Journal of Medicine Takeda UK
27 Apr 16 Phase 3 Trial Results for First Oral Proteasome Inhibitor NINLARO (ixazomib) Published in The New England Journal of Medicine Takeda Pharmaceutical Company Limited,
Published by
Business Wire
05 Apr 16 Takeda Launches Multi-Year Research Partnership with Leading Inflammatory Bowel Disease Institutions Takeda ,
Published by
PharmiWeb.com
30 Mar 16 Takeda and Lundbeck Receive Complete Response Letter for Brintellix® (vortioxetine) sNDA Takeda ,
Published by
PharmiWeb.com
15 Mar 16 Takeda and Frazier Healthcare Partners Launch Outpost Medicine to Develop New Therapeutics in Urology and Gynecology Takeda Pharmaceutical Company Limited,
Published by
Business Wire
05 Feb 16 FDA Psychopharmacologic Drug Advisory Committee Supports the Effectiveness of Brintellix® (vortioxetine) in Treating Certain Aspects of Cognitive Dysfunction in Major Depressive Disorder (MDD) Takeda Pharmaceutical ,
Published by
PharmiWeb.com
05 Feb 16 Takeda Reports Results for Three Quarters (April-December) of FY2015, Reaffirms Management Guidance for the Full Year Takeda ,
Published by
PharmiWeb.com
03 Feb 16 Mersana Therapeutics and Takeda Expand Partnership to Advance Development of Fleximer® Antibody-Drug Conjugates and XMT-1522 Takeda Pharmaceutical Company Limited,
Published by
Business Wire
03 Feb 16 Takeda Reports Results for Three Quarters (April-December) of FY2015, Reaffirms Management Guidance for the Full Year Takeda Pharmaceutical Company Limited,
Published by
Business Wire
29 Jan 16 Boehringer Ingelheim's Gilotrif® (afatinib) demonstrated superiority to Iressa® (gefitinib) in reducing the risk of disease progression and treatment failure in first-line treatment of patients with EGFR mutation-positive advanced non-small cell lung cancer Takeda Pharmaceuticals,
Published by
PharmiWeb.com
29 Jan 16 FDA Approves Takeda's Dexilant SoluTab (dexlansoprazole) Takeda Pharmaceuticals,
Published by
PharmiWeb.com
24 Jan 16 European Commission Approves Label Variation for ADCETRIS® (Brentuximab Vedotin) to Include Data on Retreatment of Adult Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma (sALCL) Takeda Pharmaceutical,
Published by
PharmiWeb.com
22 Jan 16 European Commission Approves Label Variation for ADCETRIS® (Brentuximab Vedotin) to Include Data on Retreatment of Adult Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma (sALCL) Takeda Pharmaceutical Company Limited,
Published by
Business Wire
12 Jan 16 Takeda and enGene Establish Strategic Alliance to Develop Novel Therapeutics for Gastrointestinal Diseases Takeda Pharmaceutical Company Ltd.,
Published by
Business Wire
08 Jan 16 Takeda to Present at the 34th Annual J.P. Morgan Healthcare Conference Takeda ,
Published by
PharmiWeb.com
08 Jan 16 Takeda and NsGene Partner to Perform Research in Cell Encapsulation Therapies for Parkinson's Disease Takeda ,
Published by
PharmiWeb.com
08 Jan 16 Takeda and Enterome Enter Strategic Drug Discovery Collaboration Focused on Microbiome Targets Across Multiple Gastrointestinal Disorders Takeda ,
Published by
PharmiWeb.com
08 Jan 16 Takeda Acquires U.S. Biologics Manufacturing Facility Takeda ,
Published by
PharmiWeb.com
28 Dec 15 CORRECTING and REPLACING Takeda Provides Further Information about Its New Business Venture with Teva Takeda Pharmaceutical Company Limited,
Published by
Business Wire
28 Dec 15 Takeda Provides Further Information about Its New Business Venture with Teva Takeda Pharmaceutical Company Limited,
Published by
Business Wire
08 Jan 16 Takeda Announces Details of New Business Venture with Teva in Japan Takeda ,
Published by
PharmiWeb.com
18 Dec 15 Takeda's "Leuplin® PRO for Injection Kit 22.5 mg" Now Available for the Treatment of Prostate Cancer/Premenopausal Breast Cancer in Japan Takeda,
Published by
PharmiWeb.com
18 Dec 15 Kyoto University's Center for iPS Cell Research Application and Takeda Launch the Joint Program for iPS Cell Applications Research at the Shonan Research Center (T-CiRA) Takeda,
Published by
PharmiWeb.com
18 Dec 15 Takeda Announces Sale of Respiratory Portfolio to AstraZeneca Takeda ,
Published by
PharmiWeb.com
18 Dec 15 Benefit/Risk Profile Remains Positive for Pioglitazone as an Important Treatment Option for Type 2 Diabetes Takeda Pharmaceutical,
Published by
PharmiWeb.com
15 Dec 15 Kyoto University's Center for iPS Cell Research Application and Takeda Launch the Joint Program for iPS Cell Applications Research at the Shonan Research Center (T-CiRA) Takeda Pharmaceutical Company Limited,
Published by
Business Wire
08 Jan 16 Takeda Provides Further Information about its New Business Venture with Teva Takeda ,
Published by
PharmiWeb.com
16 Dec 15 Takeda Announces Sale of Respiratory Portfolio to AstraZeneca Takeda Pharmaceutical Company Limited,
Published by
Business Wire
06 Jan 16 Takeda Acquires U.S. Biologics Manufacturing Facility Takeda Pharmaceutical Company Limited,
Published by
Business Wire
08 Jan 16 Takeda to Present at the 34th Annual J.P. Morgan Healthcare Conference Takeda Pharmaceutical Company Limited,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.